|
" Nuclear Medicine in Clinical Oncology : "
edited by Cuno Winkler.
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
721110
|
| Doc. No
|
:
|
b540815
|
| Main Entry
|
:
|
edited by Cuno Winkler.
|
| Title & Author
|
:
|
Nuclear Medicine in Clinical Oncology : : Current Status and Future Aspects\ edited by Cuno Winkler.
|
| Publication Statement
|
:
|
Berlin, Heidelberg: Springer Berlin Heidelberg, 1986
|
| ISBN
|
:
|
3540161643
|
|
|
:
|
: 3642709478
|
|
|
:
|
: 9783540161646
|
|
|
:
|
: 9783642709470
|
| Contents
|
:
|
I. Introduction and Basic Considerations --;Nuclear Oncology: Current Role and Future Direction --;Nuclear Principles of Tumor Detection --;Mechanisms Responsible for Radioactive Tracer Uptake in Malignancies --;II. Technical Principles --;Gamma Camera Imaging and Single Probe Detection of Tumors --;Single Photon and Positron Emission Computerized Tomography in Tumor Diagnosis --;NMR Tomography of Cancer: Technical Considerations --;Parameter-Selective Proton NMR Imaging and Tissue Characterization In Vivo --;Development of Magnetic Resonance Contrast Media for Tumors --;Computer-Assisted Echographic Tissue Characterization in Tumor Diagnostics --;III. Diagnostic Use of Radiopharmaceuticals --;Clinical Aspects of Detection and Imaging of Brain Tumors --;Noncontact Eye Tumor Imaging with a Gamma Camera --;Clinical Aspects of Detection and Imaging of Differentiated Thyroid Tumors --;Clinical Aspects of Detection and Imaging of Lung Tumors --;Clinical Aspects of Detection and Imaging of Tumors of Liver and Spleen --;Use of Scintigraphy for Evaluation of Patients with Renal Malignancies --;Scintigraphy of Lymphokinetics and Lymphatic Neoplasia --;Bone Scintigraphy in Primary Malignant Bone Tumor --;Scintigraphic Detection of Bone Metastases --;Metaiodobenzylguanidine in the Diagnosis of Neuroblastomas --;Scintigraphic Imaging of Pheochromocytomas by Means of Metaiodobenzylguanidine (MIBG) --;Nuclear Medicine in the Diagnosis of Skin Tumors --;IV. Radioimmunodetection --;Principles of Radioimmunodetection of Tumors --;Immunoscintigraphy of CEA-Producing Tumors with Special Emphasis on the Use of Mab Fragments and ECT --;Beta-hCG and Related Germ Cell Tumor Antigens in Radioimmunodetection --;Radioimmunodetection with Monoclonal Antibodies Against Prostatic Acid Phosphatase --;Immunoscintigraphy of Ovarian Cancer by Means of HMFG2 Monoclonal Antibody --;Immunoscintigraphy of Gynaecological Tumors --;Radioimmunoscintigraphy by Means of Melanoma Antibody --;Radioimmunoscintigraphy of CA 19-9/CEA Producing Tumors Using I-131 Labeled F (ab?)2 Fragments of Monoclonal Antibodies (19-9/Anti-CEA Radioimmunococktail) --;Radioimmunodetection of Malignant Melanoma with Radiolabelled (131I, 123I, 111In, 99mTc) Monoclonal Antibodies and F (ab?)2 Fragments --;Imaging of Bone and Soft Tissue Tumors Using an Antitumor Monoclonal Antibody --;V. Nuclear Magnetic Resonance Imaging and In Vivo Spectroscopy --;Current Status of Magnetic Resonance Imaging of the Central Nervous System --;NMR Imaging of Tumors in the Body Stem --;NMR In Vivo Spectroscopy in Tumor Diagnosis --;VI. Positron Emission Tomography --;Production and Use of Positron-Emitting Test Substances for Tumor Diagnosis --;Uptake of 11C-Aminocyclopentane Carboxylic Acid (ACPC) and 13N-Ammonia in Malignant Tumors. A Comparative Clinical Study --;Analysis of Brain Tumor Physiology by Positron Emission Tomography --;VII. Use of Tumor Markers In Vitro --;Overview of the Development of Tumor Markers --;The Clinical Value of Tumor-Associated Proteins in Gastrointestinal Cancer --;The Value of Tumor Markers in the Diagnosis of Urogenital Carcinoma --;Tumor Markers for Monitoring Therapy in Lung Cancer --;Tumor Markers for Follow-Up of Thyroid Carcinoma --;Use of Tumor Markers for Patient Monitoring in Breast Cancer --;Tumor Markers for Monitoring Breast Cancer Patients --;VIII. Therapeutic Use of Radiopharmaceuticals Including Labelled Antibodies --;Radioiodine Treatment of Thyroid Carcinomas --;Therapy of the Neuroblastoma with 131I-MIBG --;Treatment of Pheochromocytomas with 131I-Metaiodobenzylguanidine --;Treatment of Neuroblastoma by 131I-Metaiodobenzylguanidine (131I-MIBG): Qualitative and Quantitative Scintigraphic Evaluation of the Treatment Effect --;Endolymphatic Radionuclide Therapy (ELRT) in Malignant Melanoma of the Lower Extremities --;On the Efficacy of Strontium-89 Therapy. Preliminary Evaluation of a Double-blind Study --;Cancer Treatment with Radioactive Labeled Antibodies --;Treatment of Pleural and Peritoneal Carcinosis with Radioactive Colloids --;Treatment of Hepatic Malignancies by Intravascular Administration of Radioisotopes --;Treatment of Local Prostatic Cancer by 125Iodine Seeds --;CT-Guided Stereotactic Implantation with Iridium-192 and Iodine-125 of Non-Resectable Intracranial Tumors --;IX. Experimental Approaches and Future Aspects --;Radioimmunodetection of Hodgkin Tumors in Nude Mice --;Immunoscintigraphy of Human Pancreatic Carcinoma in Nude Mice with F(ab?)2 Fragments of Monoclonal Antibodies to CA 19-9 and CEA --;Physico-chemical Properties and Biokinetics of Tumor-Affine Metal (M)-Ligand-Complexes --;Iodoazomycin Riboside [1-(5?-iodo-5?-deoxyribofuranosyl)-2-nitroimidazole], a Hypoxic Cell Marker. In Vivo Evaluation in Experimental Tumors] --;The Potential Use of Alpha and Auger-Electron Emitting Radionuclides for Therapy --;Studies on the In Vivo Stability of 211At Labelled Albumin Particles in Mice.
|
| Abstract
|
:
|
With contributions by numerous experts
|
| Subject
|
:
|
Medicine.
|
| Subject
|
:
|
Nuclear medicine.
|
| Subject
|
:
|
Oncology.
|
| LC Classification
|
:
|
RC270.3.D53E358 1986
|
| Added Entry
|
:
|
Cuno Winkler
|
| Parallel Title
|
:
|
With contributions by numerous experts
|
| |